PE-22-28

Studied for its antidepressant and neuroprotective effects, this peptide modulates TREK-1 channels to potentially improve mood and cognitive performance.

PE-22-28

PE-22-28

Studied for its antidepressant and neuroprotective effects, this peptide modulates TREK-1 channels to potentially improve mood and cognitive performance.

  • Starting at $299
Order PE-22-28

What Is PE-22-28?

PE-22-28 is a research peptide studied for its potential antidepressant and neuroprotective properties. It is believed to work through modulation of TREK-1 potassium channels, which play a role in mood regulation, neuronal excitability, and stress response. By influencing these pathways, PE-22-28 has been investigated for its ability to support emotional resilience, cognitive clarity, and overall neurological balance.

  • Modulates TREK-1 channels involved in mood signaling.
  • Studied for antidepressant-like effects in preclinical models.
  • Supports neuronal protection and stress resilience.

Who Can Benefit from PE-22-28?

PE-22-28 may be considered for individuals seeking advanced mood and cognitive optimization support.

  • Individuals experiencing low mood or emotional dysregulation.
  • Longevity-focused patients prioritizing brain protection.
  • Those exploring non-stimulant cognitive enhancement.

OUR CLIENTS LOVE US - SEE WHAT THEY'RE SAYING

Frequently Asked Questions –
Your Concierge Healthcare, Simplified

It is not an FDA-approved antidepressant. It has demonstrated antidepressant-like effects in preclinical research settings but remains investigational.

No. PE-22-28 works through potassium channel modulation rather than directly altering serotonin reuptake.

No. It is not considered a stimulant. Its effects are related to neuronal signaling modulation rather than acute neurotransmitter stimulation.

Combination strategies should only be implemented under medical supervision due to potential overlapping neurological effects.